Principal Investigator, Regenerative Medicine Program of IDIBELL
Ramon y Cajal Principal Investigator, Department of Physiology Science II, University of Barcelona
Associated Group Leader of P-CMRC
Dr. Meritxell Rovira holds a PhD from Universitry Pompeu Fabra (Barcelona, Spain). She pursued a first postdoctoral training at Johns Hopkins University-School of Medicine (USA) from 2007 to 2011. In 2012, she came back to Spain with a co-funded Marie Curie Fellowship for her second postdoctoral training at IDIBAPS (Barcelona, Spain). In 2017 she was awarded a JIN grant from MINECO to develop her own research line at CMRB. This grant supported the establishment of her independence focusing her research in the field of pancreas regeneration, diabetes and pancreatic cancer. In 2018, she was awarded a Ramón y Cajal contract from MINECO to keep working as independent investigator between UB and CMRB.
Ángel Fernández Ruiz
Ángel Fernández holds a BS in Biotechnology (2019) and an MS in Genetics & Genomics (2020) obtained at the University of Barcelona. As part of both his BS and MS training he has been part of the Evolutionary Genomics & Bioinformatics team led by Julio Rozas at UB’s Faculty of Biology. His research was focused on characterising the molecular changes responsible for the adaptive radiation of the genus Dysdera in the Canary Islands, with chemoreceptor proteins and their ecological relevance as its focal point. Currently, Ángel is working on his PhD Project focused on pancreas regeneration in Meritxell Rovira’s group.
Joan Casamitjana holds a BSc in Biology (2014) and a MSc in Biomedicine (2015) from the University of Barcelona (UB), and a PhD in Cardiovascular Sciences (2020) obtained at the University of Edinburgh (UoE). Joan is now in his first year of a MSc in Bioinformatics and Biostatistics form the Open University of Barcelona (UOC) and the UB.
Joan started his research career while still an undergrad student under the supervision of Dr. Neus Carbó (UB) where he focused his research in characterising the role of caveolin1 and CD95/FAS in the chemoresistance mechanisms in human colon cancer. During his MSc and PhD at the Centre for Regenerative Medicines (MRC CRM, UoE), Joan shifted his line of work towards the identification of human adult stem cells. In particular, he identified novel subsets of perivascular cells as mesenchymal progenitor cells with the use of new markers, including CD146, CD34, NG2 or αSMA. There, he also worked identifying adult stem cells in mouse and pig.
During these years, he has acquired expertise in cell culture techniques (primary cultures and cell lines), molecular biology, flow cytometry, histology, mice handling and imaging techniques, as well as a deep understanding of mesenchymal progenitor cells, adult stem cells and the niche interaction. Joan Casamitjana joined Meritxell Rovira’s group in March 2021.
Adrián Holguín Horcajo has a Bachelor degree in Biology and Master studies in Molecular Biomedicine, both from Autonomous University of Madrid (Madrid, Spain). As a part of his Final Degree Thesis and Final Master’s Thesis, he worked in the cardiac stem cell field in Antonio Bernad’s Lab in the Biotechnology National Centre (CNB-CSIC) in Madrid. His work was directed to the validation and characterization of a reversible immortalization model of Bmi1+ cardiac progenitor cells using a lentiviral vector. After that he was involved in the identification of the role of the Mbd3 gene inside the Bmi1+ cell genetic network. Currently, he is doing his PhD in the Rovira Group at the IDIBELL as a PhD student of the Universitat de Barcelona (Barcelona, Spain), thanks to a FPI fellowship from the Spanish Ministry of Science.